Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers

International Journal of Radiation Biology

Volumn 80, Issue 11-12, 2004, Pages 813-822

  Feinendegen, L E ^a   Neumann, R D ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE I 125; IODINE 125; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE I 125; PHENAZONE I 125; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

CELL NUCLEUS; CONFERENCE PAPER; DNA DAMAGE; DOSIMETRY; HUMAN; LINEAR ENERGY TRANSFER; MICRODOSIMETRY; PRIORITY JOURNAL; RADIATION; RADIATION ABSORPTION; RADIATION DOSE; RADIATION PROTECTION; RADIOISOTOPE DECAY; SURVIVAL;

ANIMALS; APOPTOSIS; CELL NUCLEUS; CELL PHYSIOLOGY; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRONS; HUMANS; IODINE RADIOISOTOPES; LINEAR ENERGY TRANSFER; OLIGONUCLEOTIDES; RADIATION DOSAGE; RADIOMETRY; RISK ASSESSMENT; RISK FACTORS;

MAMMALIA;

EID: 12444323503     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000400007698     Document Type: Conference Paper

References (63)

1. ADELSTEIN, S. J., KASSIS, A. I., BODEI, L. and MARIANI, G., 2003, Radiotoxicity of iodine-125 and other Auger-electron-emitting radionuclides: background to therapy. Cancer Biotherapy and Radiopharmaceuticals, 18, 301-316.
2. 125I- iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature, 265, 620-621.
3. BLOOMER, W. D., MCLAUGHLIN, W. H., WEICHSELBAUM, R. R., HANSON, R. N., ADELSTEIN, S. J. and SEITZ, D. E., 1981, The role of subcellular localization in assessing the cytotoxicity of iodine-125 labeled iododeoxyuridine, iodotamoxifen, and iodoantipyrine. Journal Radioanalytical Chemistry, 65, 209-221.
4. BOND, V. P., BENARY, V., SONDHAUS, G. A. and FEINENDEGEN, L. E., 1995, The meaning of linear dose-response relations, made evident by use of absorbed dose to the cell. Health Physics, 68, 786-792.
5. 125I in cell DNA at -196°C. International Journal of Radiation Biology, 24, 363-375.
6. 125. Journal of Chemical Physics, 38, 2930-2934.
7. CHAUDHURY, A., CHARO, J., PARAPURAM, S. K., HUNT, R. C., SELIGER, B. and KIESSLING, R., 2004, Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis in Her2/neu positive tumor cell lines. International Journal of Cancer, 108, 71-77.
8. CHO, Y. S., KIM, M.-K., CHEADLE, C., NEARY, C., BECKER, K. G. and CHO-CHUNG, Y. S., 2001, Antisense DNAs as multisite genomic modulators identified by DNA microarray. Proceedings of the National Academy of Sciences, USA, 98, 9819-9823.
9. COMMERFORD, S. L., BOND, V. P., CRONKITE, E. P. and REINCKE, U., 1980, Radiotoxicity of intranuclear 1251 atoms not bound to DNA. International Journal of Radiation Biology, 37, 547-554.
10. 125I-induced DNA double strand break: implications for repair. International Journal of Radiation Biology (in press).
11. DESOMBRE, E. R., SHAFII, B., HANSON, R. N., KUIVANEN, P. C. and HUGHES, A., 1992, Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Research, 52, 5752-5758.
12. DIEHN, B., HALPERN, A. and STÖCKLIN, C., 1976, Specific inactivation of solid carbonic anhydrase upon X-ray resonance absorption in the constituent zinc atom. Journal of the. American Chemical Society, 98, 1077-1079.
13. FEINENDEGEN, L. E., 1975, Biological damage from the Auger effect, possible benefits. Radiation and Environmental Biophysics, 12, 85-99.
14. FEINENDEGEN, L. E., 1991, Radiation risk of tissue late effect, a net consequence of probabilities of various cellular responses. European Journal of Nuclear Medicine, 18, 740-751.
15. FEINENDEGEN, L. E., 2003, Relative implications of protective responses versus damage induction at low-dose and low-dose rate exposures, using the microdose approach. Radiation Protection Dosimetry, 104, 337-346.
16. FEINENDEGEN, L. E., BOND, V. P. and BOOZ, J., 1994, The quantification of physical events within tissue at low levels of exposure to ionizing radiation. ICRU News, 2, 9-13.
17. FEINENDEGEN, L. E., BOND, V. P. and SONDHAUS, C. A., 2000, The dual response to low-dose irradiation: induction vs. prevention of DNA damage. In T. Yamada, G. Mothersill, B. D. Michael and C. S. Potten (eds), Biological Effects of Low Dose Radiation (Amsterdam: Elsevier). pp. 3-17.
18. FEINENDEGEN, L. E., BOOZ, J., BOND, V. P. and SONDHAUS, C. A., 1985, Microdosimetric approach to the analysis of cell responses at low dose and low dose rate. Radiation Protection Dosimetry, 13, 299-306.
19. FEINENDEGEN, L. E., HENNEBERG, P. and TISLJAR-LENTULIS, G., 1977, DNA strand breakage and cell repair in human kidney cells after exposure to incorporated iodine-125 and Co-60 g-rays. Current Topics in Radiation Research Quarterly, 12, 436-452.
20. FEINENDEGEN, L. E., POLLYCOVE, M. and SONDHAUS, C. A., 2003, Responses to low doses of ionizing radiation in biological systems. Nonlinearity in Biology-Toxicology-Medicine (in press).
21. HOFER, K. G., 1996, Biophysical aspects of Auger processes. Acta Oncologica, 35, 789-796.
22. HOFER, K. G. and BAO, S. P., 1995, Low-LET and high-LET radiation action of 1251 decays in DNA: effect of cysteamine on micronucleus formation and cell killing. Radiation Research, 141, 183-192.
23. 125I decays in DNA. Acta Oncologica, 35, 825-832.
24. INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS, 1983, Microdosimetry. Report 36 (Bethesda: ICRU).
25. INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS, 1998, Fundamental Quantities and Units for Ionizing Radiation. Report 60 (Bethesda: ICRU).
26. INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS, 2002, Absorbed Dose Specification in Nuclear Medicine. Report 67 (Bethesda: ICRU).
27. KARAMYCHEV, V. N., PANYUTIN, I. G., NEUMANN, R. D. and ZHURKIN, V. B., 2000, DNA and RNA folds in transcription complex as evidenced by iodine-125 radioprobing. Journal of Biomolecular and Structural Dynamics, 11, 155-167.
28. KARAMYCHEV, V. N., REED, M. W., NEUMANN, R. D. and PANYUTIN, I. G., 2000, Distribution of DNA strand breaks produced by iodine-123 and indium-111 in synthetic oligonucleotides. Acta Oncologica, 39, 687-692.
29. KARAMYCHEV, V. N., ZHURKIN, V. B., GARGES, S., NEUMANN, R. D. and PANYUTIN, I. G., 1999, Detecting the DNA kinks in a DNA-CRP complex in solution with iodine-125 radioprobing. Nature Structural Biology, 6, 747-750.
30. KASID, U. and DRITSCHILO, A., 2003, RAF antisense oligonucleotide as a tumor radiosensitizer. Oncogene, 22, 5876-5884.
31. KASSIS, A. I. and ADELSTEIN, S. J., 1980, A rapid and reproducible method for the separation of cells from radioactive media. Journal of Nuclear Medicine, 21, 88-90.
32. 125I in mammalian cells. Radiation Research, 111, 305-3128.
33. KRIEG, A. M., YI, A. K., MATSON, S., WALDSCHMIDT, T. J., BISHOP, G. A., TEASDALE, R., KORETZKY, G. A. and KLINMAN, D. M., 1995, CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
34. LASTER, B. H., SHANI, G., KAHL, S. B. and WARKENTIEN, L., 1996, The biological effects of Auger electrons compared with α-particles and Li ions. Acta Oncologica, 35, 917-923.
35. LEE, L. K. and ROTH, C. M., 2003, Antisense technology in molecular and cellular bioengineering. Current Opinion in Biotechnology, 5, 505-511.
36. LI, W., 2002, Iodine-125 Induced DNA Strand Breakage: Contributions of Different Physical and Chemical Radiation Action Mechanisms. Report 12/02 (Munich: GSF-National Research Center for Environment and Health).
37. 3H]TdR incorporated in the DNA of human lymphoblast cells. Mutation Research, 111, 387-404.
38. MARTIN, R. F. and HASELTINE, W. A., 1981, Range of radiochemical damage to DNA with decay of iodine-125. Science, 213, 896-898.
39. MIYAZAKI, N. and FUJIWARA, Y., 1981, Mutagenic and lethal effects of [5-125I]iodo-2′-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs. Radiation Research, 88, 456-465.
40. 125I-bovine serum albumin. Radiation Research, 133, 182-186.
41. MOSS, E. G., 2001, RNA interference: it's a small RNA world. Current Biology, 11, R772-R775.
42. NIKJOO, H., PANYUTIN, I. G., TERRISOL, M., VRIGNEAUD, J. M. and LAUGHTON, C. A., 2000, Distribution of strand breaks produced by Auger electrons in decay if 125I in triplex DNA. Acta Oncologica, 39, 707-712.
43. PAINTER, R. B., YOUNG, B. R. and BURKI, H. J., 1973, Non-repairable strand breaks induced by 125I incorporated into mammalian DNA. Proceedings of the National Academy of Sciences, USA, 71, 4836-4838.
44. PANYUTIN, I. G., LUU, A. N., PANYUTIN, I. G. and NEUMANN, R. D., 2001, Strand breaks in whole plasmid DNA produced by the decay of (125)I in a triplex forming oligonucleotide. Radiation Research, 156, 158-166.
45. PANYUTIN, I. G. and NEUMANN, R. D., 1994, Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides. Nucleic Acids Research, 22, 4979-4982.
46. PANYUTIN, I. G. and NEUMANN, R. D., 1996, Sequence-specific DNA double-strand breaks induced by triplex-directed decay of iodine 125. Acta Oncologica, 35, 817-823.
47. PANYUTIN, I. G. and NEUMANN, R. D., 1997, Radioprobing of DNA: distribution of DNA breaks produced by decay of 1251 incorporated into a triplex-forming oligonucleotide correlates with the geometry of the triplex. Nucleic Acids Research, 25, 883-887.
48. PANYUTIN, I. G., WINTERS, T. A., FEINENDEGEN, L. E. and NEUMANN, R. D., 2000, Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. Quarterly Journal of Nuclear Medicine, 44, 256-267.
49. PANYUTIN, I. G., WINTERS, T. A., FEINENDEGEN, L. E. and NEUMANN, R. D., 2003, Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. In L. E. Feinendegen, W. W. Shreeve, W. C. Eckelman, Y.-W. Bahk and H. N. Wagner (eds), Molecular Nuclear Medicine: The Challenge of Genomics and Protomics to Clinical Practice (Berlin: Springer), pp. 697-712.
50. PASTWA, E., NEUMANN, R. D., MEZHEVAYA, K. and WINTERS, T. A., 2003, Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiation Research, 159, 251-261.
51. POMPLUN, E., 2000, Auger electron spectra. Acta Oncologica, 39, 673-579.
52. POMPLUN, E., BOOZ, J. and CHARLTON, D. E., 1987, A Monte-Carlo simulation of Auger cascades. Radiation Research, 111, 533-552.
53. ROBSON, T., PRICE, M. E., MOORE, M. L., JOINER, M. C., MCKELVEY-MARTIN, V. J., MCKEOWN, S. R. and HIRST, D. G., 2000, Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: implications for induced radioresistance. International Journal of Radiation Biology, 76, 617-623.
54. ROSSI, H. H., 1967, Energy distribution in the absorption of radiation. Advances in Biological and Medical Physics, 11, 27-85.
55. ROSSI, H. H. and KELLERER, A. M., 1972, Radiation carcinogenesis at low doses. Science, 78, 200-202.
56. SASTRY, K. S. R., HOWELL, R. W., RAO, D. V., MYLAVARAPU, V. B., KASSIS, A. I., ADELSTEIN, S. J., WRIGHT, H. S. A., HAMM, R. N. and TURNER, J. E., 1988, Dosimetry of Auger emitters: physical and phenomenological approaches. In K. F. Baverstock and D. E. Charlton (eds), DNA Damage by Auger Emitters (London: Taylor & Francis), pp. 27-38.
57. SEDELNIKOVA, O. A., PANYUTIN, I. G., THIERRY, A. R. and NEUMANN, R. D., 1998, Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells. Journal of Nuclear Medicine, 39, 1412-1418.
58. SEDELNIKOVA, O. A., ROGAKU, E. P., PANYUTIN, I. G. and BONNER, W. M., 2002, Quantitative detection of (125)IdU-induced DNA double strand breaks with gamma-H2AX antibody. Radiation Research, 158, 486-492.
59. SHINOHARA, K., NAKANO, H. and O'HARA, H., 1996, Detection of Auger enhancement induced in HeLa cells labeled with iododeoxyuridine and irradiated with 150kV x-rays - effects of cysteamine and dimethylsulfoxide. Acta Oncologica, 35, 869-875.
60. SUN, J. S. and HELENE, C., 2003, Oligonucleotides and derivatives as gene-specific control agents. Nucleosides Nudeotides and Nucleic Acids, 5-8, 489-505.
61. TUSCHL, T., 2001, RNA interference and small interfering RNAs. Chembiochemistry, 4, 239-245.
62. XUE, L. Y., BUTLER, N. J., MAKRIGIORGOS, G. M., ADELSTEIN, S. J. and KASSIS, A. I., 2002, Bystander effect produced by radiolabeled tumor cells in vivo. Proceedings of the National Academy of Sciences, USA, 99, 13765-13770.
63. ZAMECNIK, P. C. and STEPHENSON, M. L., 1978, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proceedings of the National Academy of Sciences, USA, 75, 280-284.